Our latest products

  • SORACAP – 200MG Sorafenib

    2,800.00 2,000.00

    Sorafenib is an oral targeted kinase inhibitor used to treat advanced renal cell carcinoma (kidney cancer), unresectable hepatocellular carcinoma (liver cancer), and radioactive iodine-resistant differentiated thyroid cancer.

    How to Take It

    • Form & Dosage: It is available as a 200 mg tablet. The standard dosage is typically 400 mg (two tablets) taken twice daily.
    • Administration: Tablets should be swallowed whole with a glass of water. It is generally recommended to take sorafenib either on an empty stomach or with a low-to-moderate-fat meal, as a high-fat meal can reduce the drug’s absorption and efficacy.

    Common Side Effects
    Patients taking sorafenib may experience several side effects. Common ones include:

    • Dermatological: Hand-foot skin reaction (redness, pain, or peeling on the palms and soles), rash, and dry skin.
    • Gastrointestinal: Diarrhea, nausea, vomiting, and decreased appetite.
    • Systemic: Fatigue, weakness, and weight loss.
    • Cardiovascular: High blood pressure (hypertension).

     

  • IMACAP-100MG Imatinib

    1,400.00 1,000.00

    Imatinib is a prescription medication used to treat Acute Lymphoblastic Leukemia, Myelodysplastic/Myeloproliferative Disease, Hypereosinophilic Syndrome and/or Chronic Eosinophilic Leukemia, Chronic Myeloid Leukemia Philadelphia-Chromosome-Positive, Dermatofibrosarcoma Protuberans, Mastocytosis, and Gastrointestinal Stromal Tumors.

  • LENVACAP 4MG – Lenvatinib

    1,500.00 1,300.00

    LENVACAP® (lenvatinib), a prescription medicine that may help treat people with certain kinds of cancer.

  • OSIM-80 Osimertinib

    2,100.00

    OSIM-80 (Osimertinib)/ Azd9291 is kinase inhibitor of the epidermal growth factor receptor (EGFR).

  • Osimeritinib-osim-40-mg

    OSIM-40 Osimertinib

    1,500.00

    OSIM-40 Osimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR).

  • Dasatinib-20-mg

    DASA-20 Dasatinib

    12,000.00

    DASA-20 Dasatinib is a medicine that targets specific proteins in cancer cells and stops the cancer cells
    from growing. It is used to treat some kinds of leukemia.